Stocks · Basic Materials · Chemicals - Specialty
Ingevity Corporation NGVT
$72.41 +1.86% Close, Oct 2, 2026 · NYSE · Market cap $2.49B
High qualityStrong trend
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- At 49.3× trailing earnings, the shares trade at the highest P/E of the company's past five years.
- Net debt is 5.9× EBITDA, a high level of leverage.
- Revenue over the last four quarters was $1.16B, down 12.4% from a year earlier, slowing from -10.3% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Basic Materials sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 8%
- FCF growth (TTM, YoY)Top 43%
- Revenue growth, 3-year CAGRBottom 12%
- Revenue growth accelerationBottom 23%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 20%
- Gross marginTop 20%
- Operating marginTop 15%
- Cash conversion (OCF / net income)Top 8%
- Accruals (lower is better)Top 22%
- Net debt / EBITDA (lower is better)Bottom 14%
- Interest coverBottom 43%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 47%
- Free-cash-flow yieldTop 28%
- EBITDA / enterprise valueBottom 39%
- Sales / enterprise valueBottom 33%
- P/E vs own 5-year history (lower is better)Bottom 1%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 37%
- 6-month returnTop 35%
- 1-year return vs S&P 500Top 24%
- Distance from 52-week highTop 7%
- Trend checklist (0–4)Top 4%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 16%
- Consecutive EPS beatsTop 32%
- Share of analysts rating BuyTop 19%
- Upside to consensus price targetBottom 8%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 13%
- Maximum drawdown, 3 yearsTop 37%
- Beta vs S&P 500 (lower is better)Bottom 26%
- Net debt / EBITDA (lower is better)Bottom 14%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -10.3% | -12.4% | ↓ |
| Gross margin | 36.5% | 41.1% | ↑ |
| Operating margin | 21.8% | 21.6% | ↓ |
| FCF margin | 11.3% | 13.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -12.4% | -10.3% | ↓ | Bottom 8% |
| Gross margin | 41.1% | 36.5% | ↑ | Top 20% |
| Operating margin | 21.6% | 21.8% | ↓ | Top 15% |
| Net margin | 4.7% | -16.3% | ↑ | — |
| Free-cash-flow margin | 13.3% | 11.3% | ↑ | — |
| Return on invested capital | 12.3% | — | Top 20% | |
| Revenue growth, 3-year CAGR | -11.2% | — | Bottom 12% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -10.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.6%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -7.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 5.95×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 3.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 5.46%
- Shareholder yield
- 5.46%
- Share count change, 1 year
- -2.2%
- Share count change, 3-year CAGR
- -0.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 30, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +36.9%
- Average 2-day reaction, last 8
- +0.0%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $71.50
- Target vs current price
- -1.3%
- Analysts with a rating
- 13
- Share rating Buy or Strong Buy
- 77%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +30.8% | -5.2% | +1.5% | -7.3% | — |
| May 6, 2026 | +36.9% | +1.0% | -7.2% | -13.1% | -5.2% |
| Feb 25, 2026 | -12.8% | -2.1% | -0.6% | -2.3% | -7.1% |
| Nov 5, 2025 | +92.6% | +3.6% | -5.8% | -0.1% | +27.9% |
| Aug 4, 2025 | +36.3% | +1.1% | +26.9% | +44.5% | +38.8% |
| May 5, 2025 | +33.8% | +1.4% | +15.5% | +16.2% | +20.9% |
| Feb 18, 2025 | +227.6% | +1.6% | +2.2% | -1.9% | -4.2% |
| Oct 29, 2024 | +83.3% | -1.2% | +17.3% | +40.5% | +28.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $1.74 | $1.33 | +30.8% | $314.1M |
| May 6, 2026 | $1.15 | $0.84 | +36.9% | $258.0M |
| Feb 25, 2026 | $0.58 | $0.67 | -12.8% | $255.1M |
| Nov 5, 2025 | $1.31 | $0.68 | +92.6% | $333.1M |
| Aug 4, 2025 | $1.39 | $1.02 | +36.3% | $365.1M |
| May 5, 2025 | $0.99 | $0.74 | +33.8% | $284.0M |
| Feb 18, 2025 | $0.95 | $0.29 | +227.6% | $298.8M |
| Oct 29, 2024 | $1.10 | $0.60 | +83.3% | $376.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 49.3× | 16.7× | 100th | Bottom 47% |
| P/E (forward) | 13.5× | — | — | — |
| EV / EBITDA | 18.9× | — | — | Bottom 39% |
| EV / Sales | 3.13× | — | — | Bottom 33% |
| Free-cash-flow yield | 6.22% | — | — | Top 28% |
| Earnings yield | 2.03% | — | — | Bottom 47% |
P/E over the past five years
Range 11.8× – 47.8× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- Days above the 200-day average
- 9
- 50-day average slope (20 days)
- -2.1%
- 200-day average slope (20 days)
- +2.5%
- Distance from 50-day average
- +1.0%
- Distance from 200-day average
- +3.1%
- RSI (14)
- 57.3
- Relative volume
- 0.64×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 27.8%
- Volatility vs own 5-year history
- 1th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.38
- Correlation with S&P 500
- 0.41
- Current drawdown from 1-year high
- -7.0%
- Maximum drawdown, 3 years
- -45.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 17, 2023 | Apr 8, 2025 | -67.1% | 535 days | Not yet recovered |
| May 17, 2021 | Mar 7, 2022 | -36.7% | 203 days | 232 days (Feb 7, 2023) |
| Jan 6, 2021 | Jan 29, 2021 | -16.2% | 16 days | 30 days (Mar 15, 2021) |
| Oct 16, 2020 | Oct 28, 2020 | -14.3% | 8 days | 8 days (Nov 9, 2020) |
| Mar 15, 2021 | Apr 20, 2021 | -11.5% | 25 days | 9 days (May 3, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.49B
- P/E (TTM)
- 49.3
- EPS, diluted (TTM)
- $1.47
- Revenue (TTM)
- $1.16B
- 52-week range
- $45.85 – $79.29
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.39B | $1.67B | $1.69B | $1.41B | $1.17B |
| Gross profit | $512.8M | $570.1M | $471.9M | $454.7M | $461.5M |
| Operating income | $307.2M | $341.0M | $256.4M | $259.9M | $261.9M |
| Net income | $118.1M | $211.6M | -$5.4M | -$430.3M | -$167.1M |
| EPS (diluted) | $2.95 | $5.50 | -$0.15 | -$11.85 | -$4.61 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $376.9M | $298.8M | $284.0M | $365.1M | $333.1M | $255.1M | $258.0M | $314.1M |
| Net income | -$107.2M | $16.6M | $20.5M | -$146.5M | $43.5M | -$84.6M | $59.8M | $35.3M |
| EPS (diluted) | -$2.95 | $0.45 | $0.56 | -$4.02 | $1.18 | -$2.37 | $1.66 | $1.00 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $293.3M | $313.4M | $205.1M | $128.6M | $331.2M |
| Capital expenditure | -$103.8M | -$142.5M | -$109.8M | -$77.6M | -$57.7M |
| Free cash flow | $189.5M | $170.9M | $95.3M | $51.0M | $273.5M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$104.7M | -$145.2M | -$87.4M | -$3.1M | -$54.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $97.4M
- Total assets
- $1.54B
- Total liabilities
- $1.49B
- Total debt
- $1.24B
- Net debt
- $1.14B
- Shareholders’ equity
- $46.9M
As of Jun 30, 2026 (filed Jul 30, 2026).
Short interest
- Shares sold short
- 1,443,989
- Days to cover
- 6.09
- Change vs previous report
- +9.7%
FINRA short interest, settlement date Sep 15, 2026.